Avoid Tata Motors: Mohindar

Avoid Tata Motors, says Rahul Mohindar, Director, viratechindia.com

Mohindar told CNBC-TV18, "For Ranbaxy Rs 480-500 is a good support zone. Probably a time to start nibbling in if the markets gets weak. Even Cipla for that matter at these levels may rally a bit more, but within pharma I would like to really toggle between a Ranbaxy and Glenmark. I think both these stocks give good medium to long term potential from these levels." He further added, "Reliance Industries looks an obvious bet for about Rs 700, nothing really big in terms of returns. Most of the heavyweights look a little stiff, but I would tend to avoid shorting some of the auto names. So, Tata Motors I would avoid. Hero Motocorp, I would not really short these candidates. So, technology, pharma and auto I would avoid shorting at these levels."